SCHEMBL4738561

SCHEMBL4738561

COc1cc2c(cc1S(=O)(=O)N1CCOCC1)-c1c(Cl)nc(N)nc1CC2

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.48
KMT2A Q03164 2/20 0.45
ALDH1A1 P00352 2/20 0.44
HSD17B10 Q99714 2/20 0.44
BRD4 O60885 1/20 0.42
BRD2 P25440 1/20 0.42
BRD3 Q15059 1/20 0.42
MAPT P10636 1/20 0.42
NPSR1 Q6W5P4 1/20 0.41
POLB P06746 1/20 0.41
MEN1 O00255 1/20 0.41
PKM P14618 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
LMNA P02545 1/20 0.40
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4741212 0.91 KMT2A (0.49) TSHRKMT2AALDH1A1MAPTPOLB
SCHEMBL4741216 0.84 TYMS (0.53) ALDH1A1
SCHEMBL4741147 0.83 ALDH1A1 (0.45) TSHRKMT2AALDH1A1HSD17B10BRD4
SCHEMBL4737442 0.83 MAPT (0.41) TSHRKMT2AALDH1A1HSD17B10BRD4
SCHEMBL4787519 0.80 TSHR (0.46) TSHRKMT2AALDH1A1HSD17B10MAPT
SCHEMBL4736846 0.78 TSHR (0.41) TSHRKMT2AHSD17B10MAPTPOLB
SCHEMBL14147958 0.76 SMN1; SMN2 (0.42) TSHRKMT2AALDH1A1HSD17B10BRD4
SCHEMBL4739051 0.76 ADORA2A (0.48) KMT2AALDH1A1MAPTNPSR1POLB
SCHEMBL14147954 0.75 ADORA2A (0.39) TSHRKMT2AALDH1A1HSD17B10MAPT
SCHEMBL14147955 0.74 ADORA2A (0.46) KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008086158-A1 BENZODIHYDROQUINAZOLINE AS PI3 KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-07-17 WO disclosed
WO-2008086158-A1 BENZODIHYDROQUINAZOLINE AS PI3 KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-07-17 WO disclosed